TLR2 and lung cancer: Although viruses usually supress or avoid host immunity, CoV-2 S has been suggested to induce inflammation via a TLR2 (or TLR4) – and MyD88-dependent dependent activation of the NF-κB pathway in human and mouse macrophages (279), and also to trigger lung cancer progression, again via TLR2 (331).